Kadmon Holdings, Inc.
(NYSE : KDMN)

( )
KDMN After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
CELGCelgene Corporation
-0.79%79.141.2%$541.48m
AMGNAmgen Inc.
-0.28%185.991.2%$522.30m
GILDGilead Sciences, Inc.
0.08%71.520.9%$518.25m
BIIBBiogen Inc.
0.16%297.341.2%$439.96m
NKTRNektar Therapeutics
-3.97%55.865.6%$383.38m
SRPTSarepta Therapeutics, Inc.
-2.63%149.6516.6%$325.83m
VRTXVertex Pharmaceuticals Incorporated
-0.67%156.571.9%$253.87m
REGNRegeneron Pharmaceuticals, Inc.
-2.34%329.042.6%$243.76m
ILMNIllumina, Inc.
-0.56%286.053.5%$191.71m
AAgilent Technologies, Inc.
0.40%63.041.5%$180.09m
BLUEBluebird Bio, Inc.
2.32%187.3515.7%$156.91m
ALXNAlexion Pharmaceuticals, Inc.
1.04%125.812.0%$149.34m
EXASExact Sciences Corporation
-0.74%68.8225.5%$144.87m
BMRNBioMarin Pharmaceutical Inc.
0.09%98.434.4%$139.42m
INCYIncyte Corporation
-1.28%72.492.5%$126.38m

Company Profile

Kadmon Holdings, Inc. is a biopharmaceutical company, which engages in discovering, developing, and commercializing small molecules and biologics. Its products include Ribasphere RibaPak, Tetrabenazine, Valganciclovir, Abacavir, Entecavir, Lamivudine, and Zidovudine. The company was founded by Steven N. Gordon in September 2010 and is headquartered in New York, NY.